Rational use of mucoactive medications to treat pediatric airway disease
نویسندگان
چکیده
منابع مشابه
Medications to treat alcoholism.
Advances in neurobiology support the development of medications to treat alcoholism by modifying the activity of specific chemical messengers (i.e., neurotransmitters) in the brain. Among the most promising new medications is acamprosate, which appears to decrease the intensity of craving after a person has stopped drinking. Naltrexone (ReVia) has been shown to decrease alcohol consumption, alt...
متن کاملMucoactive agents for airway mucus hypersecretory diseases.
Airway mucus hypersecretion is a feature of a number of severe respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF). However, each disease has a different airway inflammatory response, with consequent, and presumably linked, mucus hypersecretory phenotype. Thus, it is possible that optimal treatment of the mucus hypersecretory element of...
متن کاملThe pharmacologic approach to airway clearance: mucoactive agents.
The term "mucoactive agent" refers to any medication used to improve the clearance of airway secretions. It is not synonymous with the word "mucolytic" as this strictly means a drug that decreases the viscosity of secretions. In many cases, decreased viscosity will adversely affect cough transport. For this reason many of the older mucolytic agents such as acetylcysteine are not effective for t...
متن کاملDifficult-to-treat-pediatric Crohn’s disease: focus on adalimumab
Adalimumab is a fully humanized anti-tumor necrosis factor alpha monoclonal antibody that was recently granted regulatory approval in the USA for the treatment of moderate to severe Crohn's disease (CD) in children. Like infliximab, the first biologic agent used to treat pediatric CD, regulatory approval was secured many years following approval for adults. The long delay between adult and pedi...
متن کاملTreatment of Inflammatory Airway Disease: Aerosol Delivery Devices and Medications
Successful treatment of inflammatory airway disease (IAD) requires environmental management to minimize exposure to irritants and combination drug therapy to reduce pulmonary inflammation and prevent bronchoconstriction. Aerosolized drug therapy is an efficient means of treatment for most horses with IAD. Aerosolized drug therapy has been standard treatment for human patients with non-infectiou...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Paediatric Respiratory Reviews
سال: 2020
ISSN: 1526-0542
DOI: 10.1016/j.prrv.2020.06.007